All the news Showing 10 of 87 articles from: HIVGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources High incidence of HCV reinfection among HIV-positive MSM in Western Europe Michael Carter / 19 April 2016 There is a very high incidence of hepatitis C virus (HCV) reinfection among HIV-positive men who have sex with men (MSM) in western Europe, according to research presented to the International Liver Congress ... Starting HIV therapy associated with improvements in liver function, especially when viral load is suppressed Michael Carter / 21 March 2016 Starting antiretroviral therapy is associated with improvements in liver function in HIV-positive men with and without viral hepatitis co-infection, investigators from the United States report in the online edition of the Journal of ... Sofosbuvir/velpatasvir for hepatitis C can be administered with most antiretrovirals Liz Highleyman / 11 March 2016 Sofosbuvir/velpatasvir, a forthcoming combination that effectively treats all hepatitis C virus (HCV) genotypes, can be safely used with most boosted antiretrovirals for people with HIV and HCV co-infection, according to a study presented ... More than 2 million people co-infected with HIV and hepatitis C Manual Items / 08 March 2016 Sofosbuvir plus ribavirin shows suboptimal efficacy for acute hepatitis C Liz Highleyman / 25 February 2016 A combination of sofosbuvir (Sovaldi) and ribavirin cured more than 90% of hepatitis C in people living with HIV and acute hepatitis C virus (HCV) infection in a small study, but a similar ... Leading Canadian researcher calls for inclusion of co-infected people in large HCV clinical trials CATIE / 07 July 2015 Two interferon-free regimens show high HCV cure rates for people with HIV and HCV co-infection Liz Highleyman / 04 March 2015 A pair of two-drug, 12-week regimens containing neither interferon nor ribavirin – sofosbuvir (Sovaldi) plus either ledipasvir (the Harvoni coformulation) or daclatasvir (Daklinza) – cured hepatitis C for more than 95% of ... People living with HIV have high survival rates after liver transplants due to HCC Keith Alcorn / 12 November 2014 People with HIV – most of whom had hepatitis B or C co-infection – generally had good outcomes after liver transplantation due to hepatocellular carcinoma (HCC), with five-year survival rates similar to those ... Sofosbuvir/ledipasvir cures nearly all genotype 1 HCV for people with HIV co-infection Liz Highleyman / 10 November 2014 All but one participant treated for hepatitis C virus (HCV) with a co-formulation of sofosbuvir and ledipasvir (Harvoni) achieved sustained virological response at 12 weeks post-treatment, in a study involving people with ... People living with HIV in the US are infrequently screened for HCV Michael Carter / 24 September 2014 People living with HIV are infrequently screened for hepatitis C virus (HCV) infection, according to US research published in the online edition of Clinical Infectious Diseases. The retrospective study examined screening practices ... ← Prev1...34567...9Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive